Murphy & Mullick Capital Management
MDLN icon

Murphy & Mullick Capital Management’s Medline Inc MDLN Stock Holding History

Murphy & Mullick Capital Management’s Portfolio MDLN Stock Details MDLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$13K Hold
375
– – 0.01% 472
2026
Q2 		$14.8K Hold
375
– – 0.01% 451
2026
Q1 		$16.7K Buy
+375
New +$16.6K 0.01% 412

Other funds holding MDLN

Carlyle Group
Carlyle Group Washington, District of Columbia $8.36B AUM 14.46% 1-Year Est. Return
H&F Corporate Investors X
H&F Corporate Investors X San Francisco, California $2.46B AUM 15.37% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $704B AUM 26.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $296B AUM 23.14% 1-Year Est. Return

Murphy & Mullick Capital Management's MDLN Position: Q3 2026 in Review

Murphy & Mullick Capital Management held its Medline Inc (MDLN) position steady in Q3 2026 at 375 shares worth $13K. The position accounts for 0.01% of the portfolio, ranked #472.

Murphy & Mullick Capital Management first reported a position in MDLN in Q1 2026 and has held it in 3 quarters since. The position peaked at $16.7K in Q1 2026. 315 funds tracked by Wall St. Rank hold MDLN as of Q3 2026.

  • Murphy & Mullick Capital Management held 375 shares of Medline Inc worth $13K as of Q3 2026.
  • Murphy & Mullick Capital Management left its Medline Inc share count unchanged in Q3 2026.
  • Medline Inc made up 0.01% of Murphy & Mullick Capital Management's portfolio in Q3 2026, its #472 holding.
  • Murphy & Mullick Capital Management first reported a position in Medline Inc in Q1 2026 and has held it in 3 quarters since.
  • Murphy & Mullick Capital Management's Medline Inc position peaked at $16.7K in Q1 2026.
  • 315 funds tracked by Wall St. Rank held Medline Inc as of Q3 2026.

Based on Murphy & Mullick Capital Management's 13F filing for Q3 2026, filed 2 Nov 2026.